Here, we show that betulin, a sterol regulatory element-binding protein 2 (SREBP2) inhibitor, markedly enhances the anti-tumor effect of lenvatinib in HCC bothin vitro andin vivo. This evidence concerns the gene SREBF2 and hepatocellular carcinoma.